Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
BIIB080 for Alzheimer's Disease
Recruiting0 awardsPhase 2
Phoenix, Arizona
This trial is testing a study drug called BIIB080 for people with mild cognitive impairment or mild dementia due to AD. The goal is to see if the drug can slow the worsening of AD more than placebo.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.